Novartis AG company logo
Novartis AG logo

Novartis AG (NVS) Depreciation & Amortization

Annual D&A

$5.35B$713.30M-11.76%

Summary

Current Value
As of today, NVS annual D&A is $5.35B, down -11.76% on
Historical Performance
NVS annual D&A is down -20.33% over the past 3 years, up +4.74% over the past 5 years
All-Time High Comparison
NVS annual D&A is currently -35.34% below its historical high of $8.28B set on
3-Year Low Comparison
NVS annual D&A is at its 3-year low
Sector Comparison
NVS annual D&A is higher than 99.91% of companies in Healthcare sector

Depreciation & Amortization Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

NVS Performance
MetricDateValue1Y3Y5Y15Y
Annual D&A$5.35B-11.8%-20.3%+4.7%+116.0%
Quarterly D&A$1.55B-4.5%-15.3%+490.9%+1144.8%
TTM D&A$5.35B-11.8%-20.3%+4.7%+116.0%
Price$163.10+51.4%+86.4%+77.2%+225.4%
Annual SG&A$0.00-100.0%-100.0%-100.0%-100.0%
Annual Total Expenses$40.76B+6.3%+12.5%+0.4%+0.6%
Annual Operating Expenses$24.57B+11.4%+20.1%+8.2%-7.2%
Annual Revenue$54.81B+9.0%+29.6%+12.6%+9.2%

Depreciation & Amortization Highs

NVS Annual D&A Highs Comparison
PeriodHighDateCurrent
3Y$8.28B-35.3%
5Y$8.28B-35.3%
All$8.28B-35.3%

Depreciation & Amortization Lows

NVS Annual D&A Lows Comparison
PeriodLowDateCurrent
3Y$5.35Bat low
5Y$5.11BN/A+4.7%
All$890.68M+500.9%

Depreciation & Amortization History

YearValueChange
$5.35B-11.8%
$6.07B-26.7%
$8.28B+23.2%
$6.72B+23.7%
$5.43B+6.2%
$5.11B-12.3%
$5.83B+11.5%
$5.22B+0.2%
$5.21B-2.6%
$5.35B+2.4%
$5.23B+19.8%
$4.36B-6.5%
$4.66B+1.4%
$4.60B-2.3%
$4.71B+89.9%
$2.48B+9.8%
$2.26B-1.9%
YearValueChange
$2.30B-19.5%
$2.86B+48.6%
$1.92B+14.5%
$1.68B+26.1%
$1.33B+4.5%
$1.27B-1.5%
$1.29B+24.9%
$1.04B+16.3%
$890.68M-11.2%
$1.00B+4.7%
$957.81M+7.5%
$890.68M-43.1%
$1.57B-1.5%
$1.59B+16.2%
$1.37B+5.9%
$1.29B-

FAQ

  • What is the current annual D&A of NVS?

    As of today, NVS annual D&A is $5.35B

  • What is 1-year change in NVS annual D&A?

    NVS annual D&A is down -11.76% year-over-year

  • What is 3-year change in NVS annual D&A?

    NVS annual D&A is down -20.33% over the past 3 years

  • How far is NVS annual D&A from its all-time high?

    NVS annual D&A is currently -35.34% below its historical high of $8.28B set on December 31, 2023

  • How does NVS annual D&A rank versus sector peers?

    NVS annual D&A is higher than 99.91% of companies in Healthcare sector

  • When is NVS next annual earnings release?

    As of today, the next annual earnings release for NVS has not been scheduled

Data Sources & References

  1. NVS Official Website www.novartis.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1114448/000111444826000007/0001114448-26-000007-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm
  4. NVS Profile on Yahoo Finance finance.yahoo.com/quote/NVS
  5. NVS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvs